Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational …

C Di Carlo, V Gargano, S Sparice… - Gynecological …, 2013 - Taylor & Francis
This study shows the effect of a 1 year treatment with an estradiol valerate/dienogest pill in
36 women suffering from polycystic ovaries and mild or moderate acne. At beginning of the …

Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris

D Mango, S Ricci, P Manna, GAD Miggiano, GB Serra - Contraception, 1996 - Elsevier
The effect of gestodene 75 μg (GTD) versus desogestrel 150 μg (DSG) combined with 30 μg
of ethinylestradiol (EE) on acne lesions and plasma androstenedione (A), total testosterone …

Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: A …

S Leelaphiwat, T Jongwutiwes… - Journal of Obstetrics …, 2015 - Wiley Online Library
Aim To compare the effects of ethinyl estradiol (EE) 30 mcg/desogestrel 150 mcg plus
spironolactone 25 mg/day (group A) versus EE 35 mcg/cyproterone acetate 2 mg (group B) …

Efficacy of a low-dose oral contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for the treatment of moderate acne: A randomized, placebo …

J Leyden, A Shalita, M Hordinsky, L Swinyer… - Journal of the American …, 2002 - Elsevier
Background: Acne is a multifactorial disease in which androgens appear to play an
important role. A low-dose oral contraceptive containing 20 μg of ethinyl estradiol and 100 …

Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d, l-norgestrel

A LEMAY, SD DEWAILLY, R GRENIER… - The Journal of Clinical …, 1990 - academic.oup.com
The effect of a low dose triphasic oral contraceptive (OC) was evaluated during a 6-month
treatment period in 41 patients (mean age, 25.4±0.7 yr) who had grade I-IV postpubertal …

A randomized controlled trial of second-versus third-generation oral contraceptives in the treatment of acne vulgaris

MP Rosen, DM Breitkopf, M Nagamani - American journal of obstetrics and …, 2003 - Elsevier
Objective: This study was undertaken to compare the clinical efficacy of second-versus third-
generation oral contraceptives in the treatment of acne. Study Design: Thirty-four women …

Evaluation of hormonal factors in acne vulgaris and the course of acne vulgaris treatment with contraceptive-based therapies in young adult women

D Borzyszkowska, M Niedzielska, M Kozłowski… - Cells, 2022 - mdpi.com
Acne vulgaris is a common chronic inflammatory skin disease, which is considered one of
the diseases of civilization due to the significant influence of environmental factors on the …

[PDF][PDF] Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate

C Charoenvisal, Y Thaipisuttikul, S Pinjaroen… - 1996 - repository.ubn.ru.nl
Objective—To compare the effects of a low-dose oral contraceptive containing desogestrel
(Marvelon) and an anti-androgenic preparation containing cyproterone acetate (Diane) in …

Oral contraceptives as anti-androgenic treatment of acne

A Lemay, Y Poulin - Journal of Obstetrics and Gynaecology Canada, 2002 - Elsevier
Although acne is seldom associated with high serum levels of androgens, it has been shown
that female acne patients have definite increases in ovarian and adrenal androgen levels …

Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel

A Volpe, M Silferi, A Mauri, P Deiana, S Angioni… - European Journal of …, 1994 - Elsevier
A new biphasic oral contraceptive (OC) containing ethinylestradiol and desogestrel (DGS) in
both phases of the cycle (7 days 40 25 μg+ 15 days 30 125 μg) was tested for its reliability …